These studies suggest that activation of IRE1α-dependent XBP-1s is coupled with inflammatory responses in both non-CF and CF AMs, and the higher levels of XBP-1s in CF AMs are proportionate to their robust inflammatory phenotype. This evidence concerns the gene ERN1 and cystic fibrosis.